Medical College of Wisconsin
CTSIResearch InformaticsREDCap

The reflex sympathetic dystrophy syndrome (RSDS). III. Scintigraphic studies, further evidence for the therapeutic efficacy of systemic corticosteroids, and proposed diagnostic criteria. Am J Med 1981 Jan;70(1):23-30

Date

01/01/1981

Pubmed ID

6109448

DOI

10.1016/0002-9343(81)90407-1

Scopus ID

2-s2.0-0019352086 (requires institutional sign-in at Scopus site)   248 Citations

Abstract

Sixty-four patients were evaluated prospectively for a reflex sympathetic dystrophy syndrome (RSDS), using quantitative clinical measurements, high-resolution roentgenography and scintigraphy. Five separate groups were identified by their clinical features, allowing us to distinguish patients with definite or incomplete forms of the RSDS as well as 16 patients with other disorders. Scintigraphy was found to be a useful diagnostic study that may also provide a method of predicting therapeutic response. Systemic corticosteroid therapy proved to be a highly effective mode of treatment for up to 90 percent of the patients with the RSDS.

Author List

Kozin F, Ryan LM, Carerra GF, Soin JS, Wortmann RL

Author

Lawrence M. Ryan MD Emeritus Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Diagnosis, Differential
Extremities
Ganglionic Blockers
Humans
Prednisone
Radiography
Radionuclide Imaging
Reflex Sympathetic Dystrophy
Stellate Ganglion